Free tool

Cell therapy stocks

We cover 22 companies grouped under the Cell therapy theme. The median market value in the group is $583.43M. Across the group, the median move over the past trading day is −1.40%. 73% of the 22 with a 200-day average trade above it. Price change over the past year runs from −27.9% to +132.9% across the middle 80 percent of the group, with a median of +32.7%.

Other lists in this group

Table

22 of 86 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
LEGNLegend Biotech Corporation$4.02BMid cap−40.44%Nov 11, 2026
IOVAIovance Biotherapeutics, Inc.$3.66BMid cap+233.88%Nov 5, 2026
MESOMesoblast Limited$2.23BMid cap+4.47%Aug 27, 2026
VCELVericel Corporation$2.17BMid cap+18.25%Nov 5, 2026
BLFSBioLife Solutions, Inc.$1.82BSmall cap+45.50%Nov 5, 2026
VORVor Biopharma Inc.$1.30BSmall cap−40.82%Nov 12, 2026
SANASana Biotechnology, Inc.$1.25BSmall cap+23.44%Nov 5, 2026
CYRXCryoport, Inc.$839.26MSmall cap+88.94%Nov 3, 2026
ALLOAllogene Therapeutics, Inc.$704.80MSmall cap+75.86%Nov 5, 2026
PROKProKidney Corp.$694.58MSmall cap−30.12%Nov 9, 2026
AUTLAutolus Therapeutics plc$620.16MSmall cap+48.41%Nov 16, 2026
KYTXKyverna Therapeutics, Inc.$546.70MSmall cap+133.33%Nov 11, 2026
CABACabaletta Bio, Inc.$545.94MSmall cap+116.67%Nov 16, 2026
CAPRCapricor Therapeutics, Inc.$481.97MSmall cap+49.76%Nov 10, 2026
IPSCCentury Therapeutics, Inc.$392.93MSmall cap+315.53%Nov 12, 2026
LYELLyell Immunopharma, Inc.$362.68MSmall cap+37.32%Nov 6, 2026
CLLSCellectis S.A.$344.40MSmall cap+28.09%Nov 13, 2026
RNACCartesian Therapeutics, Inc.$308.30MSmall cap−4.09%Nov 5, 2026
FATEFate Therapeutics, Inc. Common Stock$305.54MSmall cap+129.46%Nov 12, 2026
LCTXLineage Cell Therapeutics, Inc.$283.26MSmall cap−8.20%Nov 5, 2026
NKTXNkarta, Inc.$194.10MSmall cap+17.41%Nov 10, 2026
MXCTMaxCyte, Inc.$139.33MSmall cap−6.43%Nov 11, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse